Association between LGALS2 3279C>T and coronary artery disease: A case-control study and a meta-analysis

Jiangfang Lian1, Peiliang Fang2, Dongjun Dai3

  • 1Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315041, P.R. China.

Biomedical Reports
|October 4, 2014
PubMed

Insights

The LGALS2 3279C>T polymorphism may offer protection against coronary artery disease (CAD), particularly in Asian populations. This finding suggests ethnic variations in the genetic associations with CAD risk.

Area of Science:

  • Genetics
  • Cardiovascular Disease Epidemiology

Background:

  • Coronary artery disease (CAD) is a leading global cause of mortality.
  • The lectin galactoside-binding soluble-2 (LGALS2) gene is implicated in the lymphotoxin-alpha (LTA) cascade, potentially affecting CAD progression.

Purpose of the Study:

  • To investigate the association between the LGALS2 3279C>T (rs7291467) polymorphism and the risk of coronary artery disease (CAD).

Main Methods:

  • A case-control study was conducted with 562 cases and 572 controls.
  • A systematic meta-analysis was performed, including 12,093 cases and 11,020 controls, to evaluate the LGALS2 3279C>T polymorphism's contribution to CAD risk.

Main Results:

  • The case-control study found no significant association between LGALS2 3279C>T and CAD in the Eastern Han Chinese population.
  • The meta-analysis revealed a protective role for the LGALS2 3279C>T polymorphism in CAD (OR, 0.90; 95% CI, 0.82-0.97).
  • This protective effect was more pronounced in the Asian population (OR, 0.82; 95% CI, 0.71-0.94).

Conclusions:

  • The LGALS2 3279C>T polymorphism demonstrates a protective association with coronary artery disease (CAD).
  • Ethnic differences may exist in the relationship between this genetic locus and CAD risk.
  • Further research is warranted to elucidate these ethnic variations.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
948
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
492
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
616